
Established in 1984, Neuland Labs is a global Contract Development and Manufacturing Organization (CDMO) offering comprehensive services for the development of customized new chemical entities (NCEs) small molecules, and peptides. Neuland’s custom peptide synthesis services include production of peptides from milligrams to multi-kilogram scale by standard sequential chemical peptide synthesis and segment condensation strategies. Neuland Labs specializes in synthesising both linear and cyclic peptides. The company has a dedicated state-of-the-art facility for custom peptide synthesis and adheres to green chemistry principles. With capabilities spanning from small-scale clinical trial quantities to full-scale commercial supplies, Neuland has successfully developed and manufactured complex peptides from 6AA to 41AA using SPPS, LPPS and hybrid technologies for clinical trials on 10s of grams to 10s of Kgs.
For more information on our services, visit https://www.neulandlabs.com/en/cdmo-services/peptides